Ethical Approval

With regard to ethical approval of studies involving humans or animals, the following points should be noted:

1. Institutional Review Board (IRB) approval should be sought for all studies involving human subjects. Moreover, the protocol number with date should be clearly mentioned in the manuscript.
2. Clinical trials can be conducted only after regulatory approval that should conform to the USFDA guidelines or its equivalent. The approval details, including the trial ID should be clearly stated in the manuscript.
3. Animal studies require approval from the institutional animal ethics committee of the respective research institutes. These should conform to national and international guidelines on animal care and use. Proof of approval with date should be mentioned in the Methods section of the manuscript.
4. Research involving humans should conform to the Declaration of Helsinki (1964) and its later amendments. This should be clearly mentioned in the manuscript.

 

 

---

 

Conflict of Interest

SJIP is committed to upholding high ethical standards in scholarly publishing. This policy outlines the expectations and procedures regarding the disclosure and management of conflicts of interest involving authors, reviewers, editors, and other individuals, associated with the publication process.

Definition of Conflict of Interest

As per the World Association of Medical Editors (WAME), a conflict of interest exists when a participant in the publication process (author, peer reviewer, or editor) has a competing interest that could unduly influence (or be reasonably seen to do so) his or her responsibilities in the publication process. Among those responsibilities are academic honesty, unbiased conduct and reporting of research, and integrity of decisions or judgments.

Types of Conflict of Interest

Financial Ties

Direct or indirect financial interest in the subject matter within last 5 years, including the following:

1. Funding from government agencies, charities, professional, or commercial organizations.
2. Equity holdings or ownership of stock and stock options.
3. Consulting fees, as well as honoraria for advice or public speaking.
4. Payment for research, service on advisory boards or medical education companies.
5. Receipt of patents or pending patents.
6. Gifts and royalties.
7. Services that may influence work related to a specific publication.

 

Academic Commitments

1. Simultaneous involvement in multiple research projects or publications that may compromise impartiality.
2. Competitive research interests with a person involved in the editorial or review process.

 

Personal Relationships

Family, close acquaintances, competitors, or professional relationships with authors, editors or other reviewers that may influence judgment.

 

Political or Religious Ideologies

Strong political or religious convictions that may interfere with the objective assessment of scholarly content.

 

Institutional Affiliations

Affiliation with an institution or organization that may benefit or be harmed by the publication’s outcome.

 

Responsibilities of Authors, Reviewers and Editors

Authors

1. Authors should disclose all potential conflicts of interest upon submission.
2. Authors should declare all academic, financial, institutional, and personal associations, as well as political and religious ideologies, which may influence review of the manuscript.
3. Authors should explicitly state funding sources and whether the organization that funded the research participated in the collection and analyses of data, as well as interpretation and reporting of results.
4. The corresponding author should ensure that co-authors are aware of and agree to all disclosures.

Reviewers

1. Reviewers should withdraw from the review process if they have a conflict of interest.
2. Reviewers should declare any academic, financial, institutional, and personal associations with the authors, as well as political and religious ideologies, which may influence review of the manuscript.
3. Reviewers should evaluate manuscripts fairly and confidentially, regardless of personal beliefs or affiliations.

Editors

1. Editors should avoid handling manuscripts with which they have a conflict of interest.
2. Independent editors should be assigned in case of potential conflict of interest.
3. Unbiased decision-making and maintenance of confidentiality throughout the review process should be ensured.

 

Disclosure and Declaration

1. A conflict of interest disclosure statement must be included in all published articles.
2. Disclosure statement on conflict of interest should be updated if circumstances change during the review and publication process.

 

Management and Resolution of Conflicts

The Editorial Board will review disclosed conflicts on a case-by-case basis. If a significant conflict of interest is identified, the following corrective measures will be taken:

1. Editorial reassignment.
2. Public disclosure in the published article.
3. Rejection of the manuscript or retraction of a published paper.

If undisclosed conflict of interest is discovered post-publication, the following corrective measures will be taken:

1. An investigation will be conducted by impartial observers.
2. Based on the findings of the investigation, an erratum will be incorporated in a subsequent issue of the journal.

 

Transparency and Accountability

SJIP promotes transparency and expects all participants in the publishing process to act with integrity. Failure to disclose relevant conflicts will result in sanctions including publication bans or notification of the author’s institution.

 

---

 

Reproduction of Published Materials

Copyright

All articles published in SJIP are protected by copyright. Authors will retain copyright and the publisher will have the right to circulate the journal freely for educational purposes.

 

Instances Where Permission Is Required

Permission for reuse of content must be obtained under the following circumstances:

1. Reuse of full articles or substantial portions (multiple figures, illustrations, charts, tables, photographs) in any commercial or academic publication.
2. Reproduction in print or digital formats such as textbooks, websites, or media content.
3. Use in derivative works, compilations, or translations.

Permission must be obtained in writing from the rights holder, which is usually the publisher. Even if the publisher does not own the copyright, they will hold the exclusive right to grant reuse permissions. All reused material must be properly acknowledged, even if permission is not required.

 

Instances Where Permission is not Required

There is no need to request permission under the following circumstances:

 

Public Domain Content

Material in the public domain, either because copyright has expired, the material is not copyrightable, or it was explicitly released into the public domain, may be reused freely, provided it is properly acknowledged.

 

Open Access Content

Content published under a Creative Commons License may be reused without written permission. However, proper credit should be given to the original authors and journal.

 

Original Figures and Tables Created from Public Data

If a new figure or table is created based on public data or factual information not previously presented in visual form, permission is not needed. However, the source of the data must be cited.

 

Educational and Non-commercial Use

Limited reproduction for non-commercial educational purposes (classroom use, student handouts, thesis) is generally permitted without formal permission, but the original source must be cited.

 

Reuse of Author’s Own Published Work

Authors retain the right to reuse parts of their own previously published work in the following cases:

Journal Articles

1. Authors can share the preprint version anytime, anywhere.
2. Authors can post the accepted manuscript version on personal or institutional websites immediately and to repositories after the journal’s embargo period.
3. Sharing via email or research networks is allowed for non-commercial use.
4. Authors are allowed to reuse figures/tables/excerpts from prior articles in future publications, presentations, or educational materials without written permission, provided the original article is properly acknowledged.

 

Book Chapters

1. Authors of book chapters may reuse up to 10% of their previously published work in new book chapters, without written permission, as long as the original material is acknowledged.

 

Procedure for Requesting Permission

For seeking permission, the rights holder should be identified, which is usually the publisher. The request should include the following information:

1. The title, author(s), and DOI of the article.
2. A detailed description of the intended use (reproduction in a book, website, research work).
3. Where and how it will be used (commercial/non-commercial).

 

Timeline and Challenges

Permission requests can take 6-8 weeks or longer. If no response is received after multiple attempts, consider replacing the material with original content or removing it entirely to avoid delay or copyright risk. In case of deceased rights holders, contact the legal heir or estate for permission. If that is not possible, the material should be removed or replaced.

 

Respecting Copyright

Using material without permission or proper citation may lead to legal consequences or ethical concerns, or retraction of the article, depending on the severity of the violation. We encourage all users to follow copyright guidelines and give credit where it’s due.

 

 

---

 

Patient Consent

All studies involving human participants must obtain informed consent. A statement confirming that consent was secured should be included in the Methods section of the manuscript. Editors may request access to the consent forms if necessary.

 

Informed Consent Policy

SJIP requires that all studies involving human subjects adhere to the ethical principles of the Declaration of Helsinki, as well as relevant national, institutional, and local regulations. Researchers must obtain written informed consent from every participant (or their legal guardian) before including them in the study. The consent must cover both participation in the research and, where applicable, the publication of identifiable information.

 

Key Features of the Consent Process

The consent process should ensure the following:

1. Participants should receive clear and accurate information on the purpose, methodology, risks, benefits, and alternatives of the study.
2. Participants should understand this information in the context of their clinical situation or personal interest.
3. Participants should voluntarily participate without coercion or undue influence.

 

Consent for Disclosing Identity

If the manuscript includes photographs, videos, case reports, or any content that might reveal a participant’s identity, authors must obtain specific written consent for publication, even if identifying details are removed.

 

Anonymization Requirements

In order to safeguard a participant’s privacy, the following steps should be taken:

1. Clinical images must obscure the eyes, using black bars or pixelation.
2. X-rays, CT, MRI scan images and other figures must not include patient names, initials, hospital identifiers, or numbers.
3. Case reports or case series should avoid disclosing the identity of the patient.

 

Statement in Manuscript

The Methods section of the article must explicitly state that informed consent was obtained from all participants. Where applicable, details of the Ethics Committee or Institutional Review Board (IRB) and the approval number should also be provided.

 

Editorial Verification

The journal may request copies of signed consent forms at any stage of the publication process and even post-publication.

 

Non-Compliance

Manuscripts failing to meet these requirements will be rejected prior to publication or retracted post publication.

 

 

---

AI Generated Articles

SJIP is committed to maintaining the highest standards of research integrity and transparency in scientific publishing. This policy outlines the appropriate use of Artificial Intelligence (AI) tools in the preparation, review, and editorial handling of manuscripts. These policies have been triggered by the rise of generative AI and AI-assisted technologies, which are increasingly being used. They aim to provide clear guidance and promote transparency among authors, reviewers, and editors.

 

Use of AI by Authors

Acceptable Uses in Scientific Writing

Authors may use generative AI and AI-assisted technologies responsibly for the following tasks:

1. Improving grammar, spelling, and language clarity.
2. Assisting with formatting references or citations.
3. Generating summaries of already published literature.
4. Translating text.
5. Generating figures under human supervision.

These tools should only be used to improve language clarity and overseen and verified by the authors themselves.

 

Disclosure Requirement

Authors should disclose all information on the use of AI tools in the manuscript preparation, including the following:

1. Name and version of the AI tool.
2. Scope and purpose of its use.
3. A clear statement of which aspects of the study, article contents, data, or supporting files were affected/generated by AI tool usage.
4. Confirmation that authors reviewed and approved the AI-assisted content.

The disclosure should be clearly mentioned in the Acknowledgments or Methods section of the published article. This will promote transparency and build trust across the scientific community.

 

Authorship Restrictions

AI tools cannot be credited as authors or co-authors. Authorship implies responsibilities such as accountability, final approval, and ethical integrity, which AI tools cannot fulfill. Only human contributors meeting authorship criteria of ICMJE can be listed.

 

Use in Figures and Images

Authors should not use AI or AI-assisted tools to create, alter, or enhance images in submitted manuscripts. Prohibited practices include introducing or removing features in images.
Permitted adjustments include brightness or contrast enhancement that does not distort or misrepresent original data. AI-assisted image generation is only allowed if it is part of the research methodology, such as biomedical imaging. In such cases, proper attribution and tool details should be provided.

 

Unacceptable Uses

The authors should desist from the following:

1. Using AI tools to generate original scientific content, results, or interpretations without review and proper disclosure.
2. Using AI to fabricate or manipulate data or
3. Submitting AI-generated content without critical human assessment.

 

Use of AI by Reviewers

Peer review is a human responsibility requiring critical judgment that AI tools cannot replicate. Reviewers should treat manuscripts and peer review comments as confidential and should not upload them to AI platforms, even for language improvement. Moreover, reviewers are accountable for the content and accuracy of their reports.

 

Use of AI by Editors

Editors should preserve the confidentiality of submitted manuscripts and related communication. These materials should not be uploaded to AI platforms. AI should not be used to evaluate scientific content or make editorial decisions. Editorial decisions require human expertise and responsibility. Editors are accountable for every stage of the editorial process and communication with authors. Generative AI or AI-assisted technologies should not be used by the editors to assist in the evaluation or decision-making process of the manuscript.

 

Publisher Owned AI Technologies

Journal publishers may use in-house or licensed AI tools for plagiarism detection, completeness checks or reviewer selection, in accordance with RELX Responsible AI Principles. These tools ensure confidentiality and comply with bias testing and data protection standards.

 

Compliance and Enforcement

Any violation of this policy will be treated as a breach of publishing ethics and may result in:

1. Rejection of the manuscript.
2. Retraction of published articles.
3. Notification to affiliated institutions or funders.
4. Publication of an editorial notice on the article.
5. Bans from future submissions in case of serious or repeated violations.
6. All cases will be handled according to COPE Core Practices.

 

Editorial Policy

All manuscripts undergo an initial editorial assessment for scope, originality, and quality. Submissions that pass the preliminary review are subjected to a double-blind peer review, with at least two independent expert reviewers. Reviewers are selected based on subject expertise, absence of conflicts of interest, and prior review experience. Authors may be asked to revise their manuscripts based on reviewers’ comments; final acceptance lies with the Editorial Board of the journal. The average time from submission to first decision is targeted at 4-6 weeks.

 

Authorship Criteria

Authorship must reflect substantial contributions to conception, design, data acquisition, analysis, or manuscript drafting/revision. The corresponding author is responsible for ensuring that all authors meet authorship criteria and approve the final version. Contributions not meeting authorship criteria should be acknowledged separately.

 

Open Access

SJIP follows an open access policy, ensuring free availability of published material to readers worldwide.

 

Corrections, Retractions and Appeals

Errata will be issued for minor errors that do not affect the scientific validity of the article. Retractions will be issued in cases of major ethical violations, data falsification, or duplicate publication. Authors may appeal editorial decisions by submitting a written request to the Editor-in-Chief, accompanied by justifications and supporting evidence.

 

Archiving and Indexing

The journal ensures long-term digital preservation of all published content. Efforts are ongoing to index the journal in various databases for broader visibility.

 

Responsibilities of Editorial Board

Maintain academic integrity and uphold high standards of scientific publishing. Ensure timely, fair, and unbiased peer review. Safeguard confidentiality of submitted manuscripts and reviewer identities. Promote diversity, inclusivity, and equitable representation of authors and reviewers across disciplines and geographies.

 

---

 

Peer Review Policy

SJIP has transparent policies for peer review, and reviewers in this process must conduct reviews in an ethical and accountable manner. Clear communication between the journal and the reviewers is essential to facilitate consistent, fair, and timely review, which will enhance the quality of the manuscript and publications.

 

Peer Review Model

This has five steps, indicated below:

1. Manuscript submission by the author
2. Initial checking by editorial office
3. Double-blind review
4. Manuscript revision by author(s)
5. Final editorial decision

 

Peer Review Process

1. The editorial office will conduct an initial screening of all submissions to assess completeness, compliance with the journal’s criteria, and overall suitability. Any deficiencies identified during this stage will be promptly communicated to the corresponding author.
2. After addressing the comments of initial screening by the corresponding author, the manuscript will be sent for peer review.
3. The editor will select two peer reviewers of the same specialty.
4. A double-blind peer review process will be followed.
5. A reviewer should accept/decline to review a submitted article within 48 hours.
6. The period for submission of review report will be two weeks.
7. A reminder will be sent if the reviewer does not submit the review report within two weeks. If the reviewer does not respond within one week after the reminder, the manuscript will be assigned to a third reviewer. 
8. Comments of the reviewers will be sent to the corresponding author and asked to make corrections according to the comments along with a rebuttal letter.
9. The Managing Editor will mediate all interactions between reviewers and corresponding author.
10. Peer reviews will not be published

 

Selection of Peer Reviewers

1. The peer reviewers will be selected taking into consideration their expertise, reputation, specific recommendations, conflicts of interest, and previous performance.
2. Ideally, the peer reviewer should have published more than 10 articles in the past decade.

3. The peer reviewer should be free from the following potential biases:

• Should not be an author in the manuscript.
• Should not have joint publications with any author of the submitted manuscript within the past five years.
• Should not be currently working at the same institution.
• Should not be a mentor, mentee, close collaborator, or joint grant holder with any author of the submitted manuscript.

 

After Peer Review

1. The reviewers’ comments will be communicated to the author upon receipt.
2. The author will be given two weeks to address the reviewers’ comments.
3. The first reminder will be given to the author on the third week. If the author does not comply with the timelines, the second reminder will be given on the fourth week.
4. The article will be declined if no response is received after two reminders.
5. If revised article is received, it will be checked for incorporation of the suggested changes. If the changes are not incorporated, it will be sent back to the authors to incorporate the suggested changes.
6. If the revised article is approved, a letter of acceptance will be issued to the author.

 

 

---

Plagiarism Policy

SJIP follows a zero-tolerance policy towards plagiarism in all submitted manuscripts. These include the following:

1. Direct plagiarism: Copying text, figures, tables, or data verbatim from previously published sources without citation.
2. Self-plagiarism: Republishing one’s own previously published work in whole or in part, including data or images, without proper reference or disclosure.
3. Paraphrasing without attribution: Rewriting another author’s work with minor modifications but failing to acknowledge the original source.
4. Mosaic plagiarism: Mixing one’s own words with phrases, sentences, or data from other sources without acknowledgment.
5. Unattributed ideas: Presenting original concepts, hypotheses, or findings of others without credit.

 

Screening of Manuscripts

All submitted manuscripts are subjected to plagiarism detection software (iThenticate/Turnitin) prior to the peer review process. If significant overlap (>15% similarity, excluding references and standard phrases) is detected, the manuscript may be returned to the author(s) for revision, or in severe cases, rejected outright.

 

Consequences of Plagiarism

1. Minor plagiarism: Authors will be asked to revise the manuscript and provide proper citations.
2. Significant plagiarism: Manuscripts may be rejected without further review.
3. Post-publication discovery of plagiarism: If plagiarism is identified after publication, the article will be immediately retracted.

 

Responsibilities of Authors

Authors are required to ensure the following:

1. Originality of their submissions.
2. Provide proper citation and acknowledgment of all sources.
3. Obtain permission for any reproduced material (tables, figures, quotations, etc).
4. Disclose overlapping work under review or previously published.

 

Responsibilities of Reviewers and Editors

Reviewers and editors are expected to remain vigilant for possible plagiarism and report any suspected instances during the review process. The editorial board will then investigate and take necessary actions following Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) guidelines.

 

---

 

Archival Policy

SJIP recognizes the importance of permanent preservation, accessibility and security of its scholarly content. To guarantee maintenance and availability, a full archival copy of each article is stored in electronic format. Additionally, authors are encouraged to self-archive the final PDF version of their published articles into institutional and public repositories without requiring permission from the journal or publisher.

Note: All policies are subject to periodic review and updating in line with evolving standards of scholarly publishing, ethical guidelines, and technological advancements.

 

 

Instructions for Authors

Manuscript submission to SJIP is online and the following supporting documents must be submitted during submission:

1. Cover letter (except for letters to the editor)
2. Ethical approval form
3. Author undertaking form

Ethical and Regulatory Compliance

1. Human Research: Institutional Ethics Committee (IEC)/Institutional Review Board (IRB) approval and written informed consent from participants are mandatory and should be mentioned in the Methods section.
2. Animal Research: Institutional and national guidelines should be followed, including adoption of the 3Rs (Replacement, Reduction, Refinement).
3. Clinical Trials: The trials must be pre-registered. Registration number should appear in the Abstract and Methods sections.

 

Manuscript Preparation

Title and Front Matter

1. Titles should be concise and ideally reflect the main result or conclusion. Vague or question-based titles should be avoided.
2. A running title (≤ 50 characters) in the header should be included in all pages.
3. All pages should be numbered.
4. Author names and full affiliations with the highest education qualification, corresponding author contact details (e-mail, official address with telephone/WhatsApp number) and ORCID ID should be included.
5. An author should be defined according to internationally accepted guidelines, primarily those of the ICMJE. Any person who is not fulfilling the criteria for authorship, should be included under acknowledgment.

Abstract and Keywords

1. The abstract should be ≤ 300 words and may be structured/non-structured, based on the article type.
2. Abbreviations or references should not be present within the abstract.
3. Approximately 3-8 keywords should be provided.

Main Body of Text

In case of original research articles, the text should be structured into the following sections:

1. Introduction: Study context, rationale, and objectives.
2. Materials and Methods: Full details of experimental design, reagents, ethical approvals, and statistical methods employed.
3. Results: Demographic data, baseline values, major findings, and statistical analysis data
4. Discussion: Interpretation, limitations, comparison with similar studies, and significance of the study.
5. Conclusion: Summary of key findings, implications of the study, recommendations for future research, and final takeaway message.
6. Acknowledgments, Funding Sources, Conflict of Interest: All relevant information on these aspects should be presented.

References

1. References should be numbered chronologically, in the order of their first appearance in the text.

1. Citation of abstracts, posters, or conference proceedings is strongly discouraged.

3. For articles accepted but not published, the terms “in press” or “forthcoming” should be used with supporting documentary proof of acceptance.
4. Unpublished data should only be cited within the text, along with the author’s written consent and labelled as “unpublished data”.
5. Citation of personal communications is discouraged, unless absolutely essential. If cited, the name of the sender and communication date should be incorporated in the text after obtaining written consent.
6. Review articles may be cited for overview purposes but should not replace citations of primary original research where available.
7. Excessive referencing should be avoided by prioritizing important original research.
8. Authors may use reference managers like EndNote, Mendeley, or Zotero.

1. The Vancouver style of referencing should be used.

10. Whenever available, PMID or DOI should be incorporated.

Tables

1. Tables must be self-explanatory and should not duplicate textual material.
2. Tables should be created separately in MS Word format and not as embedded images.
3. Shading and color highlighting the tables should be avoided.
4. Tables should be numbered in Arabic numerals in the order of their first citation in the text.
5. A brief title should be given for each table that clearly describes the presented data.

Illustrations

Illustrations include figures, graphs, flowcharts, images and photographs. The following points pertaining to illustrations should be noted:

1. Illustrations should be self-explanatory, without repetition in tables.
2. Illustrations should be submitted in separate files.
3. Illustrations should be numbered in Arabic numerals, according to the order in which they appear in the text.
4. Images should be submitted as JPG or JPEG files and graphs should be submitted along with editable data in Excel.
5. Letters, numbers, and symbols in figures should be large enough to remain legible when the figure is reduced for publication.
6. Symbols, arrows, or letters used in photomicrographs should contrast with the background.
7. Photographs of patients must be de-identified by covering the identifiable features.
8. Illustrations must be provided with a brief informative legend below it.

Units of Measurement 

1. Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter respectively) or their decimal multiples.
2. Temperatures should be in degrees Celsius.

3. Blood pressures should be in millimeters of mercury.

Manuscript Formatting by Article Type

Manuscript Type	Abstract Structure	Abstract Word Count	Manuscript Word Count	Number of References	Tables and Figures
Original Article	Structured	300	3000	25	3
Short Communication	Unstructured	200	1500	15	2
Review	Unstructured	300	4000	35	5
Mini Review	Unstructured	200	2000	20	3
Systematic Review/Meta-analysis	Structured	300	4000	35	5
Case Report	Unstructured	200	1500	10	2
Case Series	Unstructured	200	1500	10	3
Perspective	NA	NA	1500	10	NA
Commentary	NA	NA	1500	10	NA
Hypotheses and Concepts	Unstructured	200	1500	NA	3
Technical Notes, Methods and Hypotheses	Unstructured	200	1500	NA	3
Letter to the Editor	NA	NA	700	NA	NA

NA: Not applicable

 

Supporting Documents

Cover Letter

A cover letter is an obligatory supporting document for all types of manuscripts except letter to the editor. A cover letter should include the following information:

1. Title of the manuscript.
2. What is already known on the subject.
3. What the results of the study will add.
4. How the results could help in clinical practice.

Ethical Approval of Research

The following information is mandatory:

1. IEC/IRB number.
2. Date when IEC/IRB approval was given.
3. Signature of official of IEC/IRB with stamp of the institute.
4. Letter should be on the letter head of the IRB of the institute.

Author Undertaking Form

1. All author details must be submitted, including designation, affiliation, e-mail, phone/WhatsApp numbers, highest degree, and year of study in case of students.

1. Signatures of all the authors should be present.
2. Details of contributions made by each author.
3. Disclosure of conflicts of interest (if any).
4. Disclosure of funding source(s).

Note: The order of the authors will not be changed at any stage.

Formatting And Submission

1. The manuscript should be submitted in editable formats (.docx or .tex).
2. Single-column layout in A4 size should be prepared. The line spacing should be 1.5 in 12-point Calibri font.

Publication Charges

1. The authors will not be required to pay any Article Processing Charges (APC).

 

 

---

Instructions for Reviewers

The following aspects should be kept in mind while reviewing an article:

Scope and Focus of the Journal

The reviewer should check whether the manuscript aligns with the scope and focus of the journal.

Evaluation Criteria

The criteria to be followed while peer-reviewing are tabulated below:

Criteria	Description
Originality	Whether the study is novel and provides new insights.
Scientific Rigor	Whether the hypotheses, methodology, and analyses are appropriate and robust.
Relevance	Whether the manuscript contributes to the integrative understanding of physiology.
Clarity and Structure	Whether the writing is clear and well-organized.
Ethical Standards	Whether ethical guidelines have been followed.
References and Literature	Whether sources are recent, relevant and properly cited.

 

Format of the Review

The review report should be structured into the following sections:

Confidential Comments to the Editor

1. Brief summary of the overall evaluation
2. Any concerns not suitable to share with the author, such as ethical issues and conflicts of interest.

Comments to the Authors

1. Summary of the manuscript.
2. General Comments: Scientific concerns, methodological flaws, or issues requiring major revision.
3. Specific Comments: Language, formatting, small clarifications, or additional references.

Confidentiality and Ethical Conduct

1. The manuscript is confidential and should not be shared with others.
2. No part of the work should be used by the reviewer for his/her own research.
3. Any conflicts of interest (personal, financial, or professional) should be disclosed before accepting a manuscript for review.
4. Reviews will be anonymous unless otherwise stated.

 

Aims and Scope

The SAAP Journal of Integrative Physiology (SJIP) encourages submissions that advance understanding of integrative physiology, bridge basic physiological mechanisms with disease and therapeutic processes, and foster regional and global collaboration and knowledge exchange in physiological and allied sciences. SJIP embraces studies employing cutting-edge techniques, computational modeling, and cross-disciplinary frameworks that push the boundaries of traditional physiological inquiry. Through timely dissemination of research and expert discourse, the journal supports its readership in advancing physiological knowledge, addressing global health challenges, and improving physiology education and training across diverse settings.

 

 

---

 

Target Audience

The target audience encompass the following:

1. Academic Researchers and Educators: College/university faculty, postdoctoral researchers in physiology and related disciplines.
2. Graduate and Advanced Undergraduate Students: Those engaged in regional integrative physiology research.
3. Clinical and Healthcare Professionals: Doctors, physiotherapists, and public health experts interpreting physiology for practice.
4. Industry Scientists: Those working in biotech, medical devices, and pharma with physiological relevance.
5. Policymakers and Public Health Officials: Stakeholders from South Asia, where physiological research informs health policy.
6. Interdisciplinary Scholars: Bioengineers, computational biologists, and environmental scientists, focusing on applied aspects of physiology.
7. Physiological Societies and Professional Groups: Regional and international networks promoting collaborative science.

 

 

---

 

Article Categories

SJIP accepts articles in following 17 categories:

1. Editorial
2. Original Article
3. Short Communication
4. Review
5. Mini Review
6. Systematic Review/Meta-analysis
7. Case Reports
8. Case Series
9. Images in Medicine
10. Perspective
11. Commentary
12. Medical Education
13. Hypotheses and Concepts
14. Technical Notes, Methods and Protocols
15. Student’s Corner
16. News and Events
17. Letter to the Editor